VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has raised up to £13 million in Series A funding from Abingworth, the international investment group dedicated to life sciences.
VirionHealth is a University of Warwick spinout company, set up with the support of Warwick Ventures, in 2017. Dr Laura Lane, Business Development Manager at Warwick Ventures, worked closely with Professors Nigel Dimmock and Andrew Easton to build a commercial team and secure the largest single investment into a Warwick spinout.
Warwick Ventures also helped secure translational funding from the Wellcome Trust, maintained the patents and developed the business plan that led to the investment by Abingworth.
The University of Warwick is celebrating the continued success of its spinout Interface Polymers, following the company’s most recent investment of £2m led by private capital investment group 24Haymarket.
Warwick spinout Warwick Audio Technologies has secured £3.1m in new funding, including £1.9m from Mercia Technologies PLC.
The funds raised will be used by the company to continue development and marketing of its Sonoma Model One headphone system.
Click here to view the press release from Mercia Technologies PLC.
Two Warwick spinout companies have been shortlisted in the 2017 OBN Awards.
The Royal Academy of Engineering is looking for applicants to join its Enterprise Fellowship Programme.
Open to all entrepreneurial academics and recent graduates, the programme offers up to £60,000 to help you to bring your innovative technology to market
The University of Warwick’s Professor Emerita Gillian Hundt and acclaimed theatre director Claudette Bryanston have joined forces with two digital media producers to launch a new company through Warwick Ventures.
Venturefest West Midlands launches at NEC
Venturefest West Midlands will be held at Birmingham NEC on Tuesday 27th June 2017. It will provide entrepreneurs, investors and innovators to meet, engage and exchange ideas for co-operation and collaboration, particularly in the fields of science and emerging technologies.
With around 700 delegates expected to attend this one day event attendees will be able to engage directly with high growth entrepreneurs and service providers offering products, services, advice and support.
Meherant, which is developing a novel transdermal drug delivery patch technology, is one of 40 companies shortlisted in the competition. Shortlisted entrants will pitch their ideas to a panel of experts in front of a live audience at the RSC’s annual flagship event for industry, Chemistry Means Business. This event will be held in Manchester, UK on the 13th and 14th June 2017, where a winner will be selected.
The Royal Academy of Engineering Enterprise Fellowships scheme is now open for applications. The scheme aims to stimulate creativity and innovation in engineering by offering support to academics and recent graduates interested in launching a company. Warwick Ventures Business Development Managers are available to assist any researchers interested in making an application.
Congratulations to Professor Laura Green, Head of the School of Life Sciences at the University of Warwick, who has been shortlisted for an Innovator of the Year award from the Biotechnology and Biological Sciences Research Council (BBSRC).
Warwick Ventures has supported the translation of Professor Green's research, which focuses on reducing lameness in sheep flocks. The award winners will be announced on 24 May 2017.